IAPAM's Botox Training Helps Physicians Capitalize on Botox Boom
Las Vegas, NV, August 30, 2011 -- In late 2010, Botox ® was approved by the FDA to treat chronic migraine headaches in adults. The FDA announced that Botox ® injections have been shown to be effective in the prevention of migraines, which are debilitating headaches that cause intense pulsing or throbbing pain and affect about 12% of Americans. “Chronic migraine is one of the most disabling forms of headache,” Russell Katz, MD, of the FDA, says in a news release. “Patients with chronic migraine experience a headache more than 14 days of the month. This condition can greatly affect family, work, and social life, so it is important to have a variety of effective treatment options available.”
More recently, on August 24, 2011, the FDA approved Botox ® for the treatment of adult urinary incontinence, or to treat overactive bladder control, in patients with neurological problems. The FDA has said "Botox ® can be injected into the bladder to treat those who lose bladder control because of damage to the nervous system, through conditions such as multiple sclerosis or spinal cord injury." "Allergan will try to gain approval to market Botox ® to a broader population of patients with overactive bladder," Allergan's CEO David Pyott reported earlier this month.
As uses for Botox ® continue to expand, Botox ® sales have skyrocketed in 2011. Allergan announced 2Q net income increases of 3%, primarily due to "worldwide revenue from the wrinkle treatment Botox ® [climbing] 16% to $418 million." Given the continued popularity of Botox ® as the number one minimally invasive aesthetic medicine treatment (5.4 million Botox ® procedures were preformed in 2010), and coupled with the increasing number of uses for this product, physicians expertly trained in the administration of Botox ® can capitalize on this ever growing market.
The IAPAM Training Difference
Botox ® training is the central component of the IAPAM's Aesthetic Medicine Symposium (http://www.aestheticmedicinesymposium.com) which offers comprehensive instruction on the top 5 minimally invasive procedures: Botox ® injection, soft tissue fillers; chemical peels, medical microdermabrasion and laser hair removal. The key to success in the aesthetic industry is not performing one procedures, but combining treatments giving your patients the results they desire. Moreover, “physicians now see the importance in not having Botox ® training in an unclean hotel room, and are choosing the IAPAM’s aesthetic medicine symposium since its done in a clean medical practice which gives them the opportunity to learn proper Botox ® injection technique,” says Jeff Russell, Executive Director of the IAPAM (http://www.iapam.com).
Board-certified dermatologist Dr. Jennifer Linder, emphasizes that "any effective training program should provide tips on how to give an effective consultation with each patient. This should include a thorough evaluation of the individual characteristics of the face, a comprehensive discussion with the patient regarding risks and benefits, and most importantly, how to appropriately set and manage realistic patient expectations." Fellow IAPAM faculty member, dermatologist Dr. Toni C. Stockton, instructs registrants on the latest technologies and products, from Botox ® to Dysport ®. She also educates physicians on dealing with possible adverse events due to the procedure.
For more information on the IAPAM's upcoming Aesthetic Medicine Symposium with Botox ® Training, please see http://www.iapam.com or contact the IAPAM at 1-800-219-5108 ext. 704.
Botox, Botox Cosmetic and Juvederm are trademarks of Allergan, Inc. Dysport, Restylane, Perlane are trademarks of Medicis, Inc.
About the IAPAM: The International Association for Physicians in Aesthetic Medicine (IAPAM)
The International Association for Physicians in Aesthetic Medicine is a voluntary global association of physicians and supporters, which sets standards for the aesthetic medical profession worldwide. The goal of the association is to offer education, ethical standards, credentialing, and member benefits to members around the globe. IAPAM membership is open to all licensed medical doctors (MDs), doctors of osteopathic medicine (DOs), physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: Botox ® training, medical aesthetic training, laser training, physician hCG training, and aesthetic practice business training. Additional information about the association can be accessed through the IAPAM’s website (http://www.iapam.com) or by contacting:
Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
848 N. Rainbow Blvd., #713
Las Vegas, NV 89107
1-800-219-5108 ext. 704
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release IAPAM's Botox Training Helps Physicians Capitalize on Botox Boom here
News-ID: 190084 • Views: 1870
More Releases from International Association for Physicians in Aesthetic Medicine (IAPAM)
Physicians Rejoice that the IAPAM's Training is the Best in Terms of Content, Pr …
Physicians affirm that the IAPAM's Symposium with Botox Training and the IAPAM New and Improved Clean Start ® hCG Training are, "very informative and FUN!" The latest physicians testimonials were published today on the IAPAM website. Las Vegas, Nevada, USA - March 6, 2013 -- Physician feedback on the IAPAM's Symposium with Botox training (http://iapam.com/aesthetic-medicine-symposium-botox-training) and the IAPAM's comprehensive NEW Physician Clean Start ® hCG Training (http://iapam.com/aesthetic-resources/clean-start-weight-loss-program) are consistent. The latest
IAPAM Publishes its Top Aesthetic Medicine Trends for 2013
Las Vegas, Nevada, USA - January 17, 2013 -- The International Association For Physicians in Aesthetic Medicine (IAPAM) has just released its Top Aesthetic Medicine Trends for 2013. With the Affordable Healthcare Act now moving forward, successful physicians will need to incorporate synergistic non-insurance based modalities into their practices, from advanced acne treatments to hCG for weight loss to be successful in 2013. Here are nine of the key trends the
IAPAM Adds NEW Member Spotlights to its Comprehensive Website
The IAPAM has added NEW content to its respected website: The IAPAM Member Spotlight showcases the many physicians who have successfully completed the IAPAM's hCG training and Aesthetic Medicine Symposium with Botox Training, and have successfully added aesthetic medical modalities like Botox and hCG to their practices. Las Vegas, Nevada, USA - January 10, 2013 -- Today, the IAPAM announces the launch of a series of new pages of content on
Add hCG to a Medical Practice in 2013: Attend the IAPAM's January 25 hCG Trainin …
Las Vegas, Nevada, USA - January 9, 2013 -- In 2012, there was unprecedented positive interest in hCG for weight loss. To meet the ongoing consumer demand for the hCG diet in 2013, the IAPAM is helping physicians enter this lucrative, cash-based market, by offering their NEW and IMPROVED physician-led Clean Start hCG Training in Scottsdale, Arizona on January 25, 2013. Physicians will learn and receive everything they need to
More Releases for Botox
Global Medical Botox Market Demand 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Medical Botox industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Medical Botox and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). Global Info Research offers a latest published report on Medical Botox Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a
Global Botox Market 2017 Forecast to 2022
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Botox Market 2017 Forecast to 2022 TOC and List of Figures and Tables: https://www.researchbymarkets.com/report/global-north-america-europe-and-asia-pacific-south-america-middle-east-and-africa-botox-market-2017-forecast-to-2022-2228.html Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined
Global Botox Market Outlook 2017-2022
ReportsWeb.com has announced the addition of the “Global Botox Market Forecast to 2022” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is
Global Botox Market Research Report 2017
Qyresearchreports include new market research report "Global Botox Market Research Report 2017" to its huge collection of research reports. In order to provide a comprehensive study of the global Botox market, this report takes stock of all the factors that may influence the in the near future, positively or negatively. All the major trends have been analyzed and their eventual effect on the market has been estimated. The report has been
Global Botox Market Research Report 2017
If you want to ask a sample report or make an order, please contact us: Email: email@example.com Web: http://qyresearchglobal.com/ In this report, the global Botox market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Global And China Botox Industry 2017 Market Research Report is
IAPAM's Botox ®Training for Nurse Practitioners NPs
The International Association for Physicians in Aesthetic Medicine (IAPAM) is offering industry-leading Botox ® training for Nurse Practitioners (NPs) new to the Botox/dermal filler field, or for NPs looking to hone their cosmetic injectable skills. Las Vegas, NV, October 13, 2011 -- NPs New to Botox ® Learn Everything they Need to Know at the IAPAM's Aesthetic Medicine Symposium with Botox ® Training Nurse Practitioners wanting to add Botox ® as